Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Terry Day and Anand Sharma.
Connection Strength

2.356
  1. Elective neck dissection in salivary gland malignancies: Systematic review and meta-analysis. Head Neck. 2022 02; 44(2):505-517.
    View in: PubMed
    Score: 0.202
  2. The Evolution of Care of Cancers of the Head and Neck Region: State of the Science in 2020. Cancers (Basel). 2020 Jun 11; 12(6).
    View in: PubMed
    Score: 0.183
  3. Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2018 04; 158(4):649-659.
    View in: PubMed
    Score: 0.154
  4. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer. Cancer. 2017 Dec 15; 123(24):4841-4850.
    View in: PubMed
    Score: 0.150
  5. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017 Jul 15; 123(14):2651-2660.
    View in: PubMed
    Score: 0.145
  6. Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base. Cancer. 2017 Jun 15; 123(12):2248-2257.
    View in: PubMed
    Score: 0.145
  7. Hyperbaric oxygen therapy for the treatment of radiation-induced xerostomia: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Jul; 120(1):22-8.
    View in: PubMed
    Score: 0.127
  8. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 Apr; 140(4):331-7.
    View in: PubMed
    Score: 0.119
  9. Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis. Oral Oncol. 2014 Feb; 50(2):77-83.
    View in: PubMed
    Score: 0.115
  10. Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. Laryngoscope. 2010 Feb; 120(2):236-42.
    View in: PubMed
    Score: 0.089
  11. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers. Head Neck. 2009 Apr; 31(4):493-502.
    View in: PubMed
    Score: 0.084
  12. Proximal esophageal stenosis in head and neck cancer patients after total laryngectomy and radiation. ORL J Otorhinolaryngol Relat Spec. 2008; 70(4):229-35.
    View in: PubMed
    Score: 0.079
  13. Driving performance in patients with cancer in the head and neck region: a pilot study. Arch Otolaryngol Head Neck Surg. 2007 Sep; 133(9):904-9.
    View in: PubMed
    Score: 0.075
  14. Management of paranasal sinus malignancy. Curr Treat Options Oncol. 2005 Jan; 6(1):3-18.
    View in: PubMed
    Score: 0.063
  15. Melanoma of the head and neck. Curr Treat Options Oncol. 2005 Jan; 6(1):19-30.
    View in: PubMed
    Score: 0.063
  16. Overview of the management of differentiated thyroid cancer. Curr Treat Options Oncol. 2005 Jan; 6(1):47-57.
    View in: PubMed
    Score: 0.063
  17. Salivary gland neoplasms. Curr Treat Options Oncol. 2004 Feb; 5(1):11-26.
    View in: PubMed
    Score: 0.059
  18. Oral cancer treatment. Curr Treat Options Oncol. 2003 02; 4(1):27-41.
    View in: PubMed
    Score: 0.055
  19. Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer. JCO Oncol Pract. 2021 10; 17(10):e1512-e1523.
    View in: PubMed
    Score: 0.048
  20. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. Otolaryngol Head Neck Surg. 2021 10; 165(4):536-549.
    View in: PubMed
    Score: 0.048
  21. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1109-1119.
    View in: PubMed
    Score: 0.047
  22. Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer. JCO Oncol Pract. 2020 12; 16(12):e1417-e1432.
    View in: PubMed
    Score: 0.046
  23. Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2018 12 01; 144(12):1105-1114.
    View in: PubMed
    Score: 0.041
  24. Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival. Cancer. 2018 08 01; 124(15):3181-3191.
    View in: PubMed
    Score: 0.040
  25. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
    View in: PubMed
    Score: 0.025
  26. Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope. 2008 Jul; 118(7):1180-5.
    View in: PubMed
    Score: 0.020
  27. Radiation dose, driving performance, and cognitive function in patients with head and neck cancer. Radiother Oncol. 2008 May; 87(2):304-7.
    View in: PubMed
    Score: 0.020
  28. Anaplastic thyroid carcinoma: an overview. Curr Oncol Rep. 2007 Mar; 9(2):152-8.
    View in: PubMed
    Score: 0.018
  29. Role of mitomycin in upper digestive tract stricture. Head Neck. 2007 Jan; 29(1):12-7.
    View in: PubMed
    Score: 0.018
  30. Laryngeal penetration and aspiration during swallowing after the treatment of advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg. 2005 Jul; 131(7):615-9.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.